INTRODUCTION

Intra-mitochondrial Ca
2 + concentration regulates many biological processes, such as coupling of ATP demand and supply by activation of Ca 2 + -sensitive dehydrogenases and ATPases [1, 2] and cell death by the formation of the mitochondrial permeability transition pore [3] . For Ca 2 + uptake into the mitochondria, the most well-known and characterized pathway is through the mCaUP (mitochondrial Ca 2 + uniporter), which is highly selective to Ca 2 + and driven by the large electrochemical gradient in the mitochondrial inner membranes [4] . However, the affinity of mCaUP for Ca 2 + is too low and the kinetics of Ca 2 + uptake is too slow to account for the rapid mitochondrial uptake of Ca 2 + that originates from the ER (endoplasmic reticulum)/SR (sarcoplasmic reticulum) [5, 6] . To overcome this limitation, a tight structural connection should exist between the mitochondria and the ER/SR and the presence of highly localized [Ca 2 + ] (calcium concentration) microdomains around the Ca 2 + -release site of the SR.
A close contact of the ER/SR with mitochondria, where the interorganelle distance is 10-50 nm, has been reported in different tissues [7, 8] . In rat cardiac cells, for instance, the nearest distance between the mitochondrial surfaces and the components of RyRs (ryanodine receptors) is approximately 37 nm [9] . Previously, Protasi and co-workers reported the existence of tethering structures between the SR and mitochondria in the heart and skeletal muscles by electron microscopy. They reported that the tethering structures were stably associated and could endure high osmotic pressures [10] . Csordas and co-workers reported that the isolated mitochondria from rat heart homogenates were physically coupled with the SR, which creates a high Ca 2 + microdomain for RyR2-mediated mitochondrial Ca 2 + transfer [11] . These results suggest the presence of molecular components connecting mitochondria and the SR to support mitochondrial Ca 2 + transfer. The specific proteins required for the physical contact between the ER/SR and mitochondria have been studied intensively. The Mmm1 (maintenance of mitochondrial morphology 1)-Mdm10 (murine double minute 10)-Mdm12-Mdm34 complex was reported as a molecular tether for ER-mitochondria, using genetic screening in yeast [12] . In mammalian cells, mitofusin isoforms in the ER were identified as important proteins that bridge mitochondria by engaging in homotypic and heterotypic complexes with mitofusin 1 or 2 on the mitochondrial surface [13] . In addition, the chaperone protein GRP75 (glucose-regulated protein of 75 kDa) forms a complex with VDAC1 (voltage-dependent anion channel 1) and IP 3 R1 [inositol (1, 4, 5) trisphosphate receptor 1] to support mitochondrial Ca 2 + transfer from the ER [14] . The cytosolic Ca 2 + transient is controlled by both the SR and mitochondria in the heart; therefore, we attempted to identify the essential molecular partners involved in the communication between the two membrane systems. In the present study, we provide evidence that coupling between RyR2 and VDAC2 is essential for Ca 2 + transfer from the SR to the mitochondria in the heart. 1 To whom correspondence should be addressed (email dhkim@gist.ac.kr).
EXPERIMENTAL Bacterial 2-hybrid screening
The bait was localized on the cytoplasmic region of RyR2 (RB#4: RyR2 bait number 4, His 1353 -Val 1851 ) including divergent region 2, which is one of the regions to show variability among the three isoforms. BacterioMatch II validation reporter competent cells (Stratagene) were transformed with the sequence-verified recombinant pBT plasmid (pBT-RB#4). The expression of each recombinant protein was verified by Western blot analysis with an antibody that immunoreacts with the full-length bacteriophage λ repressor protein (λ cI protein). We screened a mouse heart BacterioMatch 2-hybrid cDNA library in the pTRG plasmid (Stratagene) with pBT-RB#4 according to the manufacturer's protocols.
Plasmids
RyR2 cDNA [15] , a gift from Professor S.R. Wayne Chen (Department of Physiology and Pharmacology, University of Calgary, Calgary, Canada), was used as the PCR template for the generation of the cytoplasmic RyR2 fragment (RB#4). VDAC2 was cloned from a mouse heart cDNA library in a bacterial 2-hybrid system (Stratagene). RB#4 and VDAC2 were subcloned into pGEX4T-1 (Amersham Biosciences) and pCS4-3flags and pHM6 (Roche).
Cell culture and transfection
HL-1 cells were maintained as described previously [16] . Briefly, HL-1 cells were cultured on a gelatin (0.02 %)/fibronectin (10 μg/ml) matrix and were maintained in Claycomb medium (JRH Biosciences) supplemented with 10 % (v/v) FBS (fetal bovine serum), 2 mM glutamine, 0.1 mM norepinephrine, 100 units/ml penicillin and 100 μg/ml streptomycin. HEK (human embryonic kidney)-293 FT cells were maintained in DMEM (Dulbecco's modified Eagle's medium; Gibco) with 10 % (v/v) FBS, 100 units/ml penicillin and 100 μg/ml streptomycin, and transiently transfected with VDAC2 and RB#4 plasmid DNA at 70 % confluence using Lipofectamine TM LTX (Invitrogen) according to the manufacturer's protocol.
Adult rat cardiomyocytes were isolated from 10-14-weekold male Sprague-Dawley rats (240-260 g) after anaesthesia with isoflurane and cervical dislocation [17] . All of the animal experiments were conducted after approval by the Gwangju Institute of Science and Technology Animal Care and Use Committee (permit number: GIST-2009-15) . The isolated myocytes were maintained in a 1 % BSA-Ringer solution (125 mM NaCl, 5 mM KCl, 2 mM NaH 2 PO 4 , 1.8 mM CaCl 2 , 1.2 mM MgSO 4 , 25 mM Hepes, 5 mM sodium pyruvate and 11 mM glucose, pH 7.4 adjusted with NaOH), plated on laminin-coated coverslips and incubated in DMEM containing 5 % (v/v) FBS, 100 units/ml penicillin, 100 μg/ml streptomycin, 5 mM taurine, 5 mM carnitine and 5 mM creatine. After 2 h of incubation, unattached cells were removed by washing with serum-free DMEM.
Generation and transduction of recombinant adenovirus
The oligonucleotides encoding the specific shRNA (short hairpin RNA) for VDAC2 were inserted into pSilencer Adeno 1.0-CMV vector (Ambion) downstream of the CMV (cytomegalovirus) promoter. CMV promoter-driven expression cassettes were co-transfected with an adenoviral lacZ vector into the HEK-293T 1573 cell line (A.T.C.C.) after linearization by digestion with the restriction enzyme PacI. The sequence of oligonucleotides encoding the VDAC2 shRNA was 5 -CGCTGACAAGGAGTAACTTTGC-3 . BLAST searches confirmed that the selected oligonucleotide sequence was not homologous to any other gene. AdNC was made from the negative control shuttle vector, supplied with the kit, encoding an shRNA whose sequence is not found in mouse.
For recombinant adenovirus transduction, HL-1 cells were plated at a concentration of 3×10 5 cells per well in six-well plates. Approximately 24 h after seeding, HL-1 cells were infected with AdNC or AdshVDAC2 at a MOI (multiplicity of infection) of 100. The medium was changed every day until 60 h after viral infection.
Production of recombinant lentivirus and generation of VDAC2 KD (knockdown) stable HL-1 cells
The shRNA-expressing lentiviral vector for targeting VDAC2 mRNA was constructed by inserting synthetic double-stranded oligonucleotides, the same sequence used for generating AdshVDAC2, into the shLenti2.4G vector containing a U6 small nuclear RNA promoter upstream of the multicloning sites and a GFP (green fluorescent protein) gene-IRES (internal ribosomal entry site)-puromycin resistance gene under the control of a human CMV promoter.
To create a negative control shRNA vector, luciferase mRNA targeting sequences, 5 -CTTACGCTGAGTACTTCGA-3 , were inserted into the shLenti2.4G vector. The lentiviruses were produced by co-transfection of HEK-293T cells with three plasmids: (i) a construct expressing the heterologous envelope protein VSV-G (vesicular stomatitis virus glycoprotein); (ii) a packaging defective helper construct expressing the gag-pol gene; and (iii) a transfer vector harbouring a specific shRNA sequence using Lipofectamine TM Plus (Invitrogen). At 48 h post-transfection, virus-containing culture supernatants were collected and clarified with a 0.45 mm membrane filter (Nalgene), and immediately stored in a deep freezer at − 70
• C. Titres were determined by p24 ELISA (PerkinElmer Life Science) or Western blot analysis with a monoclonal anti-p24 antibody obtained through the AIDS Research and Reference Reagent Program. In our routine preparation, titres were approximately 10 7 transduction units per millilitre without further purification.
To transduce with the lentivirus vector expressing shRNA, HL-1 cells were prepared at 70 % confluency on a 25 cm 2 flask and incubated with the shRNA-expressing lentiviruses in the presence of 8 g/ml polybrene for 8 h. The supernatant was removed after infection and replaced with a fresh medium.
GST (glutathione transferase) pull-down and co-immunoprecipitation assays
Male mice (8-10 weeks old) were killed by cervical dislocation and the heart was quickly removed. Mouse hearts were homogenized and solubilized in solubilizing buffer containing 20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 0.5 % Nonidet P40 and protease inhibitor cocktail (Calbiochem) for 30 min at 4
• C. After centrifugation at 13 000 g for 30 min at 4 • C to remove unsolubilized vesicles and precipitates, the supernatant was further cleared by incubation with glutathione-Sepharose beads for 30 min at room temperature (20 • C). The cleared supernatants were then incubated with GST-fused protein-bound affinity matrices overnight at 4
• C followed by seven washes with solubilizing buffer.
An anti-HA (haemagglutinin) antibody (Covance) was added to solubilized HA-VDAC2-or/and FLAG-RB#4-expressing HEK-293 FT cells, and incubated overnight at 4
• C. Protein GSepharose 4B beads (for the mouse primary antibody) and Protein A-Sepharose 4B beads (GE Healthcare) (for the rabbit primary antibody) were then used to precipitate the antibodies followed by three washes with solubilizing buffer.
In vitro protein-protein interaction assay [ 35 S]Methionine-labelled RB#4 was synthesized using a coupled transcription/translation TNT system (Promega). GST and GSTfusion proteins immobilized on glutathione-Sepharose beads were mixed with the in vitro translated proteins in the binding buffer containing 20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 0.2 % Nonidet P40, 1 mM PMSF and the protease inhibitor cocktail (Calbiochem), overnight at 4 • C. After seven washes with the binding buffer, the bound proteins were analysed by SDS/PAGE (10 % gels) and autoradiography.
Immunocytochemistry
Isolated adult rat cardiomyocytes and HL-1 cells were grown on glass coverslips coated with laminin or gelatin and fibronectin respectively. Immunocytochemistry were performed as described previously [18] . Mouse anti-RyR2 (Affinity Bioreagents) and rabbit anti-VDAC2 primary antibodies, raised against a synthetic peptide (N 118 TGKKSGKIKSAYKREC 134 ) from mouse VDAC2, were used for staining RyR2 and VDAC2 respectively. Alexa Fluor ® 488-conjugated anti-mouse and Alexa Fluor ® 594-conjugated anti-rabbit IgG (Molecular Probes) secondary antibodies were used for detection of RyR2 and VDAC2 respectively. The slides were examined with an LSM 700 confocal laser-scanning microscope (Carl Zeiss).
Electron microscopy
The cells were fixed with 2.5 % (w/v) glutaraldehyde dissolved in 0.15 M cacodylate buffer overnight at 4
• C and with 2 % (w/v) osmium tetroxide for 1 h. The cells were dehydrated with an ethanol series, infiltrated with Spurr's resin series and polymerized at 60
• C for 8 h. The embedded cells were cut with a diamond knife on an ultramicrotome (MTX-L, RMC). The sections were mounted directly on to 150 mesh nickel grids. The sections were treated with 3 % H 2 O 2 for 30 min and incubated with the AURION Blocking Agent for 30 min. Then, the sections were incubated with anti-RyR2 and anti-VDAC2 antibodies, and then rinsed with 0.1 % BSA-C (AURION) in PBS and incubated with 10 nm gold-conjugated anti-mouse antibody and 20 nm gold-conjugated anti-rabbit antibody for 1 h. After washing with 0.1 % BSA-C in PBS, the sections were treated with 0.2 % glutaraldehyde and washed with distilled water. Finally, the sections were stained with 2 % (w/v) uranyl acetate solution for 10 min, and the grids were examined with Tecnai F20 (FEI) at 200 kV.
Isolation of mitochondria
Subpopulations of mitochondria were isolated from 10-14-week-old male Sprague-Dawley rats (240-260 g) using methods described previously [19] . Briefly, rat hearts were removed and washed in ice-cold buffer A containing 100 mM KCl, 50 mM Mops, pH 7.4, 5 mM MgSO 4 , 1 mM ATP and 1 mM EGTA. Ventricles were minced in 10 ml/g of ice-cold buffer B (buffer A plus 0.04% BSA) with scissors and then homogenized with five strokes of a Teflon pistil in a glass potter. The homogenates were centrifuged for 10 min at 800 g. The supernatant was further centrifuged for 10 min at 8000 g, and the pellet was used as the SSM (subsarcolemmal mitochondrial) fraction. For the isolation of IFM (interfibrillar mitochondria), the pellets from the first centrifugation were resuspended in buffer B (10 ml/g) and treated with 8 units/g of Nagarse protease (Fluka) for 1 min on ice. The tissue was homogenized with five strokes of a Teflon pistil in a glass potter and centrifuged for 10 min at 800 g. The supernatant was further centrifuged for 10 min at 8000 g, and the pellets were used for the IFM fraction. 
Western blot analysis
Proteins were run on an SDS/PAGE gel and were electrophoretically transferred on to a nitrocellulose membrane. The transferred proteins on the nitrocellulose membrane were incubated with blocking solution containing 5 % (w/v) nonfat dried skimmed milk powder and TBST (0.1 % Tween 20 in Tris-buffered saline; 137 mM NaCl and 20 mM Tris/HCl, pH 7.4) for 1 h at room temperature. After blocking, the nitrocellulose membrane was treated with anti-VDAC2, anti-junctin [20] , anti-VDAC1 (Calbiochem), anti-VDAC3 (Abcam), anti-RyR2 (clone C3-33), anti-DHPR (dihydropyridine receptor), anti-NCX1 (sodium-calcium exchanger 1), anticalsequestrin, anti-SERCA (sarco/endoplasmic reticulum calcium ATPase), anti-phospholamban (Affinity Bioreagents), anti-(phosphorylated RyR2) (Badrilla), anti-HA (Covance), anti-FLAG, anti-(connexin 43) (Sigma), anti-(flavoprotein subunit of complex II) (Mito Sciences) and anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase; Lab Frontier) antibodies diluted in TBST solution, washed with TBST and incubated with The GST-tagged cytoplasmic region of RyR2 (RB#4) and GST-tagged VDAC2 expressed in BL21 cells were subjected to a GST pull-down assay with mouse heart whole homogenates, and the presence of RyR2 (A) or VDAC2 (B) was detected by Western blotting, using the appropriate antibodies. Beads or GST alone was also used for the pull-down assay as a control. (C) In vitro transcribed and translated RB#4 with [
35 S]methionine was incubated with GST-VDAC2 and subjected to GST pull-down, SDS/PAGE and autoradiography assays. The presence of the dark bands in the lanes indicates the radioactivity due to the radiolabelled RB#4. (D) HEK-293 FT cells were transiently co-transfected with HA-VDAC2 and FLAG-RB#4 or empty vectors. At 48 h later, VDAC2 was immunoprecipitated (IP) using an anti-HA antibody and precipitates were separated by SDS/PAGE and immunoblotted with either anti-HA or anti-FLAG antibody. Light chain, the IgG light chain. The plus or minus symbol indicates the presence or absence of each protein respectively.
horseradish peroxidase-conjugated secondary antibody (Jackson). After washing, the membranes were developed with Enhanced Chemiluminescence solution (Pierce).
Statistics
The experimental values are expressed as means + − S.E.M. Significance (P < 0.05) was determined using the Student's t test.
RESULTS
Interaction between VDAC2 and RyR2
To investigate the interacting partner of RyR2, we performed bacterial 2-hybrid screening with a mouse heart cDNA library using the cytoplasmic region (RB#4) of RyR2 as bait. Interestingly, VDAC2, located in the mitochondrial outer membrane, was identified as one of the major interaction partners (results not shown).
On the basis of this finding, we conducted biochemical studies to confirm further the interaction between VDAC2 and RyR2. As shown in Figures 1(A) and 1(B) , RyR2 and VDAC2 in mouse heart whole lysates were pulled down with GST-fused VDAC2 and RB#4 respectively. To examine the direct interaction, RB#4 radiolabelled with [
35 S]methionine was expressed in vitro and incubated with GST alone or GST-VDAC2. The radiolabelled RB#4 was detected only when the pull-down assay was performed with GST-VDAC2. We attempted to confirm further the interaction by the exogenous expression of VDAC2 and RB#4 in HEK-293T cells for the co-immunoprecipitation assay ( Figure 1D ). The results showed that the FLAG-RB#4 band was detected only when both HA-VDAC2 and FLAG-RB#4 were present in the assay system, suggesting a direct physical interaction between VDAC2 and RyR2.
Co-localization of VDAC2 and RyR2 in HL-1 cells
The co-localization of endogenous RyR2 and VDAC2 was investigated in HL-1 cells by immunocytochemistry with confocal microscopy. The distribution pattern of VDAC2 and RyR2 in HL-1 cells was depicted with pseudocolours (red and green respectively). The distribution of VDAC2 and RyR2 was clearly shown to have a mesh-like structure in the HL-1 cells. By merging the red and green images, substantial co-localization between VDAC2 and RyR2 was detected in HL-1 cells (Figure 2A ). The micrograph shows the dense co-localization around the nuclear region, suggesting the possibility that the newly synthesized proteins are fused around the nuclear region in HL-1 cells. Alternatively, the perinuclear region is where the bulk of the SR/ER and mitochondria are located.
In agreement with the previous findings that the mitochondria and the SR are in close proximity in both skeletal and cardiac muscles [9, 10] , our transmission electron microscope study showed the close apposition of mitochondria and the SR in HL-1 cells ( Figure 2B , left-hand and middle panels). The junction between the SR and mitochondria was further examined by immunogold electron microscopy. Two different-sized gold particles were used to distinguish VDAC2 from RyR2. The large and the small particles represent the localization of VDAC2 and RyR2 respectively. The two types of gold particles indicated by the white arrow show the presence of RyR2 (in the SR) and VDAC2 (in mitochondria) in close vicinity ( Figure 2C ).
Co-localization of VDAC2 and RyR2 at the subsarcolemmal region in adult ventricular cardiomyocytes
Mitochondria can be separated into two subpopulations according to their localization, one residing directly beneath the sarcolemma (SSM) and the other located interfibrillarily (IFM). These two mitochondria types differ not only in their location, but also in biochemical and physiological properties [21, 22] . To examine the distribution of VDAC2 in isolated adult rat ventricular cardiomyocytes, we first performed immunocytochemistry with anti-VDAC2 antibody. As shown in Figure 3 (A), VDAC2 molecules were distributed along the sarcolemmal membrane, whereas all VDAC isoforms were evenly distributed throughout the ventricular cardiomyocytes (Supplementary Figure S1C at http://www.BiochemJ.org/bj/447/bj4470371add.htm). As in the 3D (three-dimensional) images reconstructed from a stack of serial cross-sections of the cell, the VDAC2 expression pattern is shown as a hollow pipeline structure (Supplementary Figure S1B) . To confirm these findings, the two mitochondrial populations were isolated by differential centrifugation for Western blot analysis. Figure 3 (B) displays the localization of the three VDAC isoforms in each mitochondrial fraction. VDAC1 and VDAC3 were found to be localized in both SSM and IFM, whereas the majority of VDAC2 was detected in the SSM fraction with connexin 43, a marker for the SSM fraction [19] .
On co-immunostaining with anti-VDAC2 and anti-RyR2 antibodies, VDAC2 and RyR2 molecules were shown to be co-localized at the subsarcolemmal region of adult rat ventricular cardiomyocytes ( Figure 3C ). Western blot analysis revealed a protein band corresponding to the SR-resident CSQ2 (calsequestrin 2) in both the IFM and SSM fractions ( Figure 3D ), as previously shown [11] . However, RyR2 was only detected in the SSM fraction ( Figure 3D ), suggesting that SSM is particularly linked with the RyR2-resident SR. Taken together, VDAC2 is localized in SSM, where it is co-localized with RyR2 in rat cardiomyocytes.
Intracellular Ca 2 + transients in VDAC2 KD HL-1 cells
To investigate the effect of VDAC2 KD on Ca 2 + transients, we used an adenovirus-based shRNA gene silencing strategy using HL-1 cells. Transduction efficiencies of both AdNC (control construct) and AdshVDAC2 (KD construct) for HL-1 cells were nearly 100 % at a MOI of 100 as judged by the lacZ staining uptake by RU360 [23, 24] led us to hypothesize that KD of VDAC2 could suppress mitochondrial Ca 2 + uptake from the cytosol, and hence the diastolic [Ca 2 + ] is increased in HL-1 cells.
To investigate the mitochondrial Ca 2 + transfer mediated by the coupling between RyR2 and VDAC2, we attempted to use the lentiviral system to stably express both shRNA and EGFP (enhanced GFP). A total of 70-80 % HL-1 cells showed EGFP expression after infection of shNC or shVDAC2 lentivirus ( Figure 6A ). The KD efficacy of shRNA was measured by Western blot assay as shown in Figure 6 (B). The expression of VDAC2 was down-regulated by approximately 70 % in the stably transfected HL-1 cell line ( Figure 6B ).
To measure the local high [Ca 2 + ]-mediated Ca 2 + transfer into mitochondria, we used the high-capacity EGTA/Ca 2 + buffer (2 mM EGTA and 0.9 mM CaCl 2 ) for the internal solution after permeabilization of the cells with 10 μM of digitonin, because EGTA could efficiently suppress the caffeine-induced global increase of cytosolic [Ca 2 + ] at a distance of 100 nm, but could not attenuate the rapid increase of [Ca 2 + ] at 20 nm from the Ca 2 + -releasing area [25, 26] . Figure 6 (C) shows representative traces of Rhod-2 fluorescence in shNC-or shVDAC2-lentivirusinfected HL-1 cells. For the experiments, after permeabilization of cells with digitonin, the initial perfusion solution was rapidly changed to the internal solution and then 10 mM caffeine was applied to induce RyR2-mediated Ca 2 + release from the SR. Similar to previous reports showing Ca 2 + transfer into mitochondria through the application of RyR2 agonists [9, 25] , we observed that mitochondrial [Ca 2 + ] was rapidly increased in the presence of 2 mM EGTA in shNC-infected HL-1 cells. However, down-regulation of VDAC2 abolished mitochondrial Ca Figure 6D ). This result suggests that VDAC2 is the predominant pathway for mitochondrial Ca 2 + uptake from the high [Ca 2 + ] microdomain, which could be provided by Ca 2 + release from the SR through RyR2. Taken together, the coupling of RyR2 and VDAC2 is critical for creating the high [Ca 2 + ] microdomains and for mediating rapid mitochondrial Ca 2 + uptake.
DISCUSSION
The structural proximity between the subdomains of the SR and mitochondria, and its possible role in Ca 2 + transfer between the two membrane systems in the heart have been suggested [7] [8] [9] [10] [11] . The structural proteins involved in the formation of the juxtaposition between mitochondria and the ER/SR have also been identified [12] [13] [14] . Nevertheless, the specific molecular architecture that could contribute to the functional linkage between the SR and mitochondria remained to be resolved. In the present study, we used various biochemical and molecular methods to identify the proteins involved in the functional linkage. According to our results, RyR2 and VDAC2 are the two key proteins for the functional linkage between the SR and mitochondria at the subsarcolemmal region. RyR2-VDAC2 coupling may be important for the Ca 2 + transfer from the SR to mitochondria, creating high [Ca 2 + ] microdomains ( Figure 7) . The supporting evidence is as follows: (i) RyR2 is physically coupled with VDAC2 in the heart (Figures 1 and 2) ; (ii) RyR2-VDAC2 interaction occurs at the subsarcolemmal regions ( Figure 3) ; and (iii) experimentally manipulated VDAC2 expression significantly affects the diastolic Ca 2 + level as well as the mitochondrial Ca 2 + level (Figures 4-6 ). Previous reports showed evidence that RyRs are also localized in the IMM (inner mitochondrial membrane) and could have an important role for the dynamic Ca 2 + uptake into mitochondria [27] . Use of RyR subtype-specific antibodies revealed that the mRyR (mitochondrial RyR) was RyR1, but not RyR2 [28] . Pharmacological and functional properties of mRyR were similar to those of RyR1 in skeletal SR, but different from those of RyR2 in cardiac SR [28] . For the present study, we used the C3-33 RyR2 antibody (see the Experimental section), since the antibody was known to bind RyR2 preferentially [29] and the evidence that the antibody did not detect mRyR in the heart was shown [28] . The results of the present study of immunoprecipitation and the LC (liquid chromatography)-MS/MS (tandem MS) study also showed that the C3-33 RyR2 antibody detected RyR2, but not RyR1 or RyR3 in the heart (see Supplementary Figure S3 at http://www.BiochemJ.org/bj/447/bj4470371add.htm). Taken together, the interaction between RyR2 and VDAC2 shown in To create the model, the cryo-electron microscopic reconstruction map of rabbit RyR1 was used [45, 46] . The VDAC2 3D structure was estimated by homology modelling with the program Modeller v9 [47] on the basis of the human VDAC1 structure solved conjointly by NMR spectroscopy and X-ray crystallography [48] . In the cardiomyocytes, tethering molecules at the junction between the SR and mitochondria support the close apposition of the two subcellular organelles. The physical association of RyR2 and VDAC2 provides the high [Ca 2 + ] microdomain at the junction and facilitates mitochondrial Ca 2 + uptake through the mCaUP.
the present study (Figures 1-3) was not due to the involvement of mRyR, which is RyR1. RyR2 is a 560 kDa molecule that is responsible for SR Ca 2 + release. Its large N-terminal domain protrudes into the cytosol and serves as a scaffold to create a macromolecular complex and regulate RyR2-mediated Ca 2 + release from the SR [30, 31] . Besides the importance of RyR2 in cardiac excitation-contraction coupling, a crucial role of RyR2 for the process of mitochondrial Ca 2 + transfer has been reported [9, 11, 25] . VDAC is a pore-forming protein originally found in the OMM (outer mitochondrial membrane) of all eukaryotes. VDAC is considered the predominant pathway for Ca 2 + diffusion through the OMM into the matrix [32, 33] . Therefore VDAC has been proposed to be a Ca 2 + transport limiting factor that could create a high [Ca 2 + ] microdomain at the mouth of mCaUP in the mitochondrial inner membrane [34] . Typically, VDAC1 mediates mitochondrial Ca 2 + accumulation by physical interaction with IP 3 R1 through the molecular chaperone GRP75 [14] . However, the interaction between VDAC and RyR2 has not been studied until now.
To facilitate Ca 2 + accumulation effectively, the mouth of mitochondria should be closely located to the Ca 2 + release site of the SR (Ca 2 + microdomain), since mCaUP has a low affinity for Ca 2 + . The formation of a highly stable association of mitochondria with SR by electron-dense tethers (anchoring structure) in the fast-twitch and cardiac muscles has been studied by electron microscopy [9, 10] . The localized [Ca 2 + ] for mitochondrial Ca 2 + uptake at the junction between SR and mitochondria has been suggested to be 20-50 μM in cardiomyocytes, when cytosolic [Ca 2 + ] reaches >1 μM [9, 24, 35, 36] . Recently, it was also reported that an optimum space is necessary for IP 3 R or RyR2 to create a high [Ca 2 + ] microdomain at the junction necessary for efficient mitochondrial Ca 2 + transfer [37] . Our findings that RyR2 and VDAC2 are physically associated in the heart (Figures 1-3 signalling in various cell types [38] [39] [40] . A recent study examining spatial differences of mitochondrial Ca 2 + uptake under voltage-clamp depolarization and caffeine-evoked RyR2 Ca 2 + release showed that subsarcolemmal mitochondria were more responsive to RyR2 Ca 2 + release than perinuclear or interfibrillar mitochondria in feline ventricular cardiomyocytes [41] . Consistent with that study, we found that VDAC2 is localized mostly in the SSM and co-localized with RyR2 at the subsarcolemmal region of cardiomyocytes ( Figure 3 ). This result provides a possible mechanism for the heterogeneous kinetics of mitochondrial Ca 2 + transfer on the basis of spatial differences.
The present study has identified a novel association between two Ca 2 + channels, VDAC2 in mitochondria and RyR2 in the SR, which are thought to produce the high [Ca 2 + ] microdomain essential for mitochondrial Ca 2 + uptake ( Figure 7 ). The remaining questions such as beat-to-beat regulation of mitochondrial Ca 2 + uptake [42] [43] [44] and the physiological meaning of the mitochondrial heterogeneity await further study in the future. 
SUPPLEMENTARY ONLINE
EXPERIMENTAL
Immunopurification of mouse heart lysate
Solubilized mouse heart homogenates were obtained as described in the Experimental section of the main text. After pre-clearing of the solubilized homogenates with Protein G-Sepharose 4B beads (GE Healthcare), 10 μg of anti-RyR2 antibody (C3-33, ABR) or normal mouse IgG was added and incubated overnight at 4
• C. Protein G-Sepharose 4B beads were then used to precipitate the proteins bound to the anti-RyR2 antibody followed by three washes with solublizing buffer. The beads were eluted with 8 M urea and 100 mM Tris (pH 8.5). The pooled elutes were reduced with DTT (dithiothreitol), alkylated using iodoacetamide and digested with trypsin.
Reverse-phase HPLC and MS/MS (tandem MS) analysis
Peptide mixtures were loaded on to a 7.5 cm fused-silica capillary column (100 μm internal diameter, 360 μm outside diameter) packed with 5 μm C18 (AQUA). For the reverse phase, buffer A (5 % CH 3 CN and 0.1 % formic acid) and buffer B (80 % CH 3 CN and 0.1 % formic acid) were used. The following gradient method was performed to separate peptide mixtures for 80 min: 0-15 % buffer B for 15 min; 15-55 % buffer B for 50 min; then 100 % buffer B for 15 min. Peptides were eluted at a flow rate of 250 nl/min from a flow splitter by HPLC pumps.
Peptides were separated with an Agilent 1100 series HPLC pump (Agilent Technologies) connected to a linear quadruple ion trap mass spectrometer (LTQ, Thermo-Finnigan) using an in-house-built nano ESI (electrospray ionization) interface. In order to identify the peptides, the ion trap mass spectrometer was operated in a data-dependent MS/MS mode (m/z 400-2000) in which a full MS scan was followed by 10 MS/MS scans and the temperature of the heated capillary was 200
• C.
Data searching and analysis
Acquired MS/MS spectra were searched against an IPI mouse.v3.68 FASTA-formatted protein database (http://www. ebi.ac.uk). SEQUEST algorithm was used to find the best matching sequences from the database with BioWorks software (Thermo Finnigan) in fully tryptic mode. The mass of cysteine was statically modified by + 57 Da. X corr values were based on tryptic peptides and charge states following 1.8 for singly charged peptides, 2.5 for doubly charged peptides, 3.5 for triply charged peptides and 0.08 for C n . and MS/MS (bottom) spectra of a unique peptide for RyR2 identified in all three samples. The MS/MS spectrum of the peptide at mass to charge ratio (m/z) of 1170.98 is shown in the middle, and the letters y and b denote C-and N-terminal fragment ions respectively. As a result of the affinity purification with the anti-RyR2 antibody and analysis of the precipitates, 100/1140, 110/1237 or 93/933 (the number of identified peptides for RyR2/the number of total identified peptides) were matched with RyR2 from each experiment. However, no unique peptide responsible for RyR1 or RyR3 was detected.
